Omada Health (OMDA) CFO exercises options and sells 50,950 shares
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported option exercises and matching share sales under a pre-arranged plan. On June 26 and June 29, he exercised stock options to acquire a total of 50,950 shares of common stock at exercise prices of $8.01 and $8.28 per share, then sold 50,950 shares in open-market transactions at weighted average prices of $19.8924 and $21.0678 per share. The filing states these were same-day exercise-and-sale transactions executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026. After these transactions, Cook holds 187,209 shares of Omada Health common stock directly. This Form 4/A restates an earlier Form 4 to add previously omitted exercise transactions and correct the number of securities beneficially owned following the sales.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 50,950 shares ($1,034,616)
Net Sell
8 txns
Insider
Cook Steven L.
Role
Chief Financial Officer
Sold
50,950 shs ($1.03M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 17,950 | $0.00 | -- |
| Exercise | Common Stock | 17,950 | $8.28 | $149K |
| Sale | Common Stock | 17,950 | $21.0678 | $378K |
| Exercise | Stock Option (Right to Buy) | 13,573 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 19,427 | $0.00 | -- |
| Exercise | Common Stock | 13,573 | $8.28 | $112K |
| Exercise | Common Stock | 19,427 | $8.01 | $156K |
| Sale | Common Stock | 33,000 | $19.8924 | $656K |
Holdings After Transaction:
Stock Option (Right to Buy) — 301,809 shares (Direct, null);
Common Stock — 205,159 shares (Direct, null)
Footnotes (1)
- This Form 4/A restates in its entirety the original Form 4 filed on 6/30/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. This transaction was executed in multiple trades at prices ranging from $19.6727 to $20.078. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 100% of the shares subject to the option are fully vested and exercisable. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Shares sold: 50,950 shares
Weighted average sale price June 26: $19.8924/share
Weighted average sale price June 29: $21.0678/share
+5 more
8 metrics
Shares sold
50,950 shares
Total common shares sold in open-market transactions on June 26 and June 29, 2026
Weighted average sale price June 26
$19.8924/share
Open-market sale of 33,000 common shares on June 26, 2026
Weighted average sale price June 29
$21.0678/share
Open-market sale of 17,950 common shares on June 29, 2026
Option exercise prices
$8.01 and $8.28/share
Exercise prices for stock options converted into Omada Health common stock
Options exercised
50,950 shares
Total shares acquired through option exercises tied to M-code transactions
Shares owned after transactions
187,209 shares
Common stock directly beneficially owned by CFO after reported trades
10b5-1 plan adoption date
March 14, 2026
Date CFO adopted Rule 10b5-1 trading plan referenced in footnote
Option expiration dates
July 19, 2031 and February 8, 2034
Expiration dates for stock options referenced in M-code derivative entries
Key Terms
Rule 10b5-1 trading plan, exercise-and-sale transactions, beneficially owned, Stock Option (Right to Buy), +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
exercise-and-sale transactions financial
"The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported..."
beneficially owned financial
"Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... underlying security title: Common Stock ... underlying security shares: 17950.0000"
fully vested and exercisable financial
"100% of the shares subject to the option are fully vested and exercisable."
FAQ
What insider transactions did Omada Health (OMDA) CFO Steven Cook report?
Omada Health CFO Steven L. Cook reported exercising options for 50,950 shares and selling 50,950 common shares in open-market transactions. These same-day exercise-and-sale trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2026.
At what exercise prices did the Omada Health (OMDA) CFO exercise options?
The Omada Health CFO exercised stock options at exercise prices of $8.01 and $8.28 per share. These options were fully vested, and the exercises formed part of same-day exercise-and-sale transactions disclosed in the amended Form 4/A filing.
Why did Omada Health (OMDA) file an amended Form 4/A for its CFO?
The Form 4/A for Omada Health’s CFO restates the original Form 4 to include exercise transactions inadvertently omitted. While the related sales were timely reported, the omission understated beneficial ownership, which has now been corrected in Box 5 of Table I.